NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

抗体

CD66 Monoclonal Antibody (CD66a-B1.1), Super Bright™ 702, eBioscience

67-0668-42

100试验

美国409

单克隆

小鼠

Super Bright 702

CD66a-B1.1

CD66 Monoclonal Antibody (CD66a-B1.1), Super Bright™ 702, eBioscience

67-0668-42

100试验

美国409

单克隆

亲和色谱

小鼠

人类

Flow Cytometry: 5 µL (0.25 µg)/test

人类

CD66a-B1.1

IgG2a, kappa

4° C, store in dark, DO NOT FREEZE!

The CD66 molecules are 180-200 kDa glycoproteins of carcinoembryonic antigen family. They are present on all blood granulocytes and some tissue macrophages, but are absent from other hematopoietic cells. The expression of CD66 increases significantly on granulocytes upon their activation. CD66a (BGP1, CEACAM1) and CD66d (CGM1, CEACAM3), as well as CEACAM2 and 4, are transmembrane proteins, whereas CD66c (CEAL, NCA, CEACAM6) and CD66e (CEA, CEACAM5), as well as CEACAM7 and 8, are anchored to the plasma membrane by C-terminal glycosylphosphatidylinositol (GPI) lipid moiety.

液体

Flow Cytometry: 5 µL (0.25 µg)/test

antigen CD66; BGP; BGP1; BGP-1; BGPI; Biliary glycoprotein 1; Carcinoembryonic antigen; Carcinoembryonic antigen CGM1; carcinoembryonic antigen CGM7; carcinoembryonic antigen gene family member 1; carcinoembryonic antigen gene family member 7; carcinoembryonic antigen related cell adhesion molecule 1; carcinoembryonic antigen related cell adhesion molecule 3; carcinoembryonic antigen related cell adhesion molecule 4; carcinoembryonic antigen related cell adhesion molecule 5; carcinoembryonic antigen related cell adhesion molecule 6; carcinoembryonic antigen-related cell adhesion molecule 1; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); carcinoembryonic antigen-related cell adhesion molecule 3; Carcinoembryonic antigen-related cell adhesion molecule 4; carcinoembryonic antigen-related cell adhesion molecule 4-sv1; carcinoembryonic antigen-related cell adhesion molecule 4-sv2; carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen-related cell adhesion molecule 6; carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen); CD66a; CD66a antigen; CD66c; CD66d; CD66d antigen; CD66e; CEA; CEACAM1; CEACAM-1; CEACAM3; CEACAM-3; CEACAM4; CEACAM5; CEACAM-5; CEACAM6; CEACAM-6; CEAL; CGM1; CGM7; CGM7_HUMAN; Cluster of Differentiation 66c; meconium antigen 100; NCA; Non-specific crossreacting antigen; nonspecific cross-reacting antigen; Nonspecific cross-reacting antigen (NCA); non-specific cross-reacting antigen W236; nonspecific cross-reacting antigen W236; normal cross-reacting antigen; pan CEACAM; W264; W282